Characterization of a human homologue of proteolysis-inducing factor and its role in cancer cachexia

Clinical Cancer Research

Volumn 10, Issue 17, 2004, Pages 5862-5869

  Monitto, Constance L ^a   Dong, Seung Myung ^a   Jen, Jin ^b   Sidransky, David ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOSYLATED PROTEIN; PROTEOLYSIS INDUCING FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CACHEXIA; CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; FOOD INTAKE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOOD PROTEINS; BREAST NEOPLASMS; CACHEXIA; CLONING, MOLECULAR; DNA, COMPLEMENTARY; FEMALE; GLYCOSYLATION; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; PLASMIDS; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 4444384629     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0435     Document Type: Article

References (35)

1. Inagalo K, Rodriguez V, Bodey GP. Proceedings: causes of death in cancer patients. Cancer (Phila.) 1974;33:568-73.
2. Warren S. The immediate causes of death in cancer. Am J Med Sci 1932;184:610-5.
3. Heber D, Byerly LO, Chi J, et al. Pathophysiology of malnutrition in the adult cancer patient. Cancer (Phila.) 1986;58:1867-73.
4. Moldawer LL, Georgieff M, Lundholm K. Interleukin 1, tumor necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia. Clin Physiol 1987;7:263-74.
5. Matthys P, Dijkmans R, Proost P, et al. Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells. Int J Cancer 1991;49:77-82.
6. Mori M, Yamaguchi K, Honda S, et al. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res 1991;51:6656-9.
7. Yoneda T, Nakai M, Moriyama K, et al. Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma. Cancer Res 1993;53:737-40.
8. Zugmaier G, Paik S, Wilding G, et al. Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res 1991;51:3590-4.
9. Kawamura I, Morishita R, Tomita N, et al. Intratumoral injection of oligonucleotides to the NF-kappaB binding site inhibits cachexia in a mouse tumor model. Gene Ther 1999;6:91-7.
10. Guttridge DC, Mayo MW, Madrid LV, Wang C, Baldwin AS. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science (Wash. DC) 2000;289:2363-6.
11. Cowen DM, Double JA, Cowen PN. Some biological characteristics of transplantable lines of mouse adenocarcinomas of the colon. J Natl Cancer Inst (Bethesda) 1980;64:675-81.
12. McDevitt TM, Tisdale MJ. Tumour-associated hypoglycaemia in a murine cachexia model. Br J Cancer 1992;66:815-20.
13. Todorov PT, McDevitt TM, Cariuk P, Coles B, Deacon M, Tisdale MJ. Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res 1996;56:1256-61.
14. Todorov PT, Deacon M, Tisdale MJ. Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation. J Biol Chem 1997;272:12279-88.
15. Hussey HJ, Todorov PT, Field WN, et al. Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with aproteolysis inducing factor. Br J Cancer 2000;83:56-62.
16. Todorov PT, Field WN, Tisdale MJ. Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361). Br J Cancer 1999;80:1734-7.
17. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cancer cachectic factor. Nature (Lond.) 1996;379:739-42.
18. Lorite MJ, Cariuk P, Tisdale MJ. Induction of muscle protein degradation by a tumour factor. Br J Cancer 1997;76:1035-40.
19. Lorite MJ, Thompson MG, Drake JL, Carling G, Tisdale MJ. Mechanism of muscle protein degradation induced by a cancer cachectic factor. Br J Cancer 1998;78:850-6.
20. Bloomquist BT, Eipper BA, Mains RE. Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA. Mol Endo 1991;5:2014-24.
21. Harlow E, Lane D. Immunoprecipitation. In: Using antibodies: a laboratory manual. New York: Cold Spring Harbor Laboratory Press; 1999. p. 231.
22. Noel A, Simon N, Raus J, Foidard JM. Basement membrane components (Matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochem Pharmacol 1992;43:1263-7.
23. Osborne CK, Hobbs K, Clark GM. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 1985;45:584-90.
24. Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-402.
25. Cunningham TJ, Hodge L, Speicher D, et al. Idenfification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin. J Neurosci 1998;18:7047-60.
26. Burge C, Karlin S. Prediction of complete gene structures in human genomic DNA. J Mol Biol 1997;268:78-94.
27. Beck SA, Tisdale MJ. Production of lipolytic and proteolytic factors by a murine tumor producing cachexia in the host. Cancer Res 1987;47:5919-23.
28. Porter D, Weremowicz S, Chin K, et al. A neural survival factor is a candidate oncogene in breast cancer. Proc Natl Acad Sci USA 2003;100:10931-6.
29. Schittek B, Hipfel R, Sauer B, et al. Dermcidin: a novel antibiotic peptide secreted by sweat glands. Nat Immunol 2001;2:1133-7.
30. Wang Z, Corey E, Hass GM, et al. Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. Int J Cancer 2003;105:123-9.
31. Monitto CL, Berkowitz D, Lee KM, et al. Differential gene expression in a murine model of cancer cachexia. Am J Physiol Endocrinol Metab 2001;28:E289-97.
32. Hussey HJ, Tisdale MJ. Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model. Int J Cancer 2000;87:95-100.
33. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69:491-7.
34. Kumar S, Kishimoto H, Chua HL, et al. Interleukin-1 alpha promotes tumor growth and cachexia in MCF-7 xenograft model of breast cancer. Am J Pathol 2003;163:2531-41.
35. Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999;1473:21-34.